Cargando…

Equine influenza – surveillance and control

Please cite this paper as: Cullinane et al. (2010) Equine influenza – surveillance and control. Influenza and Other Respiratory Viruses 4(6), 339–344. Equine influenza virus (EIV) is considered the most important respiratory virus of horses because it is highly contagious and has the potential to di...

Descripción completa

Detalles Bibliográficos
Autores principales: Cullinane, Ann, Elton, Debra, Mumford, Jenny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634605/
https://www.ncbi.nlm.nih.gov/pubmed/20958927
http://dx.doi.org/10.1111/j.1750-2659.2010.00176.x
_version_ 1782399388814934016
author Cullinane, Ann
Elton, Debra
Mumford, Jenny
author_facet Cullinane, Ann
Elton, Debra
Mumford, Jenny
author_sort Cullinane, Ann
collection PubMed
description Please cite this paper as: Cullinane et al. (2010) Equine influenza – surveillance and control. Influenza and Other Respiratory Viruses 4(6), 339–344. Equine influenza virus (EIV) is considered the most important respiratory virus of horses because it is highly contagious and has the potential to disrupt major equestrian events. Equine influenza (EI) can be controlled by vaccination but it has been demonstrated repeatedly in the field that antigenic drift impacts on vaccine efficacy. EI surveillance maintains awareness of emergence and international spread of antigenic variants. It not only serves as an early warning system for horse owners, trainers and veterinary clinicians but is fundamental to influenza control programmes based on vaccination. Data on outbreaks of EI and strain characterisation is reviewed annually by an Expert Surveillance Panel (ESP) including representatives from OIE and WHO. This panel makes recommendations on the need to update vaccines based on analysis of evidence of disease in well vaccinated horses, antigenic changes, genetic changes and when possible, experimental challenge data. However, the disparity in the level of surveillance and virus collection in different countries results in potentially biased information about the relative prevalence of different viruses. There is a need for increased surveillance on a global level and a greater awareness of the benefits of updating the vaccines. The vaccine companies have traditionally been slow to respond to the ESP recommendations. Veterinary clinicians have a major role to play in purchasing vaccines with epidemiologically relevant strains and promoting their benefits to their clients.
format Online
Article
Text
id pubmed-4634605
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-46346052015-11-30 Equine influenza – surveillance and control Cullinane, Ann Elton, Debra Mumford, Jenny Influenza Other Respir Viruses Review Article Please cite this paper as: Cullinane et al. (2010) Equine influenza – surveillance and control. Influenza and Other Respiratory Viruses 4(6), 339–344. Equine influenza virus (EIV) is considered the most important respiratory virus of horses because it is highly contagious and has the potential to disrupt major equestrian events. Equine influenza (EI) can be controlled by vaccination but it has been demonstrated repeatedly in the field that antigenic drift impacts on vaccine efficacy. EI surveillance maintains awareness of emergence and international spread of antigenic variants. It not only serves as an early warning system for horse owners, trainers and veterinary clinicians but is fundamental to influenza control programmes based on vaccination. Data on outbreaks of EI and strain characterisation is reviewed annually by an Expert Surveillance Panel (ESP) including representatives from OIE and WHO. This panel makes recommendations on the need to update vaccines based on analysis of evidence of disease in well vaccinated horses, antigenic changes, genetic changes and when possible, experimental challenge data. However, the disparity in the level of surveillance and virus collection in different countries results in potentially biased information about the relative prevalence of different viruses. There is a need for increased surveillance on a global level and a greater awareness of the benefits of updating the vaccines. The vaccine companies have traditionally been slow to respond to the ESP recommendations. Veterinary clinicians have a major role to play in purchasing vaccines with epidemiologically relevant strains and promoting their benefits to their clients. Blackwell Publishing Ltd 2010-10-19 2010-11 /pmc/articles/PMC4634605/ /pubmed/20958927 http://dx.doi.org/10.1111/j.1750-2659.2010.00176.x Text en © 2010 Blackwell Publishing Ltd
spellingShingle Review Article
Cullinane, Ann
Elton, Debra
Mumford, Jenny
Equine influenza – surveillance and control
title Equine influenza – surveillance and control
title_full Equine influenza – surveillance and control
title_fullStr Equine influenza – surveillance and control
title_full_unstemmed Equine influenza – surveillance and control
title_short Equine influenza – surveillance and control
title_sort equine influenza – surveillance and control
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634605/
https://www.ncbi.nlm.nih.gov/pubmed/20958927
http://dx.doi.org/10.1111/j.1750-2659.2010.00176.x
work_keys_str_mv AT cullinaneann equineinfluenzasurveillanceandcontrol
AT eltondebra equineinfluenzasurveillanceandcontrol
AT mumfordjenny equineinfluenzasurveillanceandcontrol